Are cancer stem cells concentrated in more alkaline hypoxic regions of tumors?

Medical Hypotheses

Volumn 74, Issue 5, 2010, Pages 868-870

  Anderson, K M ^a   Jajeh, A ^a   Guinan, P ^a   Rubenstein, M ^a  

^a Hektoen Institute for Medical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER 1; NOTCH RECEPTOR; PROTON PUMP; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

ALKALINITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PH; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN LOCALIZATION; STRUCTURAL HOMOLOGY;

CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; HYDROGEN-ION CONCENTRATION; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 77950949729     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.11.027     Document Type: Article

References (29)

1. Wicha M.S., Liu S., Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 2006, 66:1883-1890.
2. Rosen J.M., Jordan C.T. The increasing complexity of the cancer stem cell paradigm. Science 2009, 324:1670-1673.
3. Harguindey S., Pedraz J.L., Garcia Canero R., et al. Hydrogen ion-dependent oncogenesis and parallel new avenues to cancer prevention and treatment using H(+)-mediated unifying approach: pH-related and pH-unrelated mechanisms. Crit Rev Oncogene 1995, 6:1-33.
4. Parmar K., Mauch P., Vergilio J.-A., et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. PNAS US 2007, 104:5431-5436.
5. Walker M.R., Patel K.K., Stappenbeck T.S. The stem cell niche. J Pathol 2009, 217:169-180.
6. Wouters A., Pauwels B., Lardon F., Vermorken J.B. Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions. The Oncologist 2007, 12:690-712.
7. Das B., Tsuchida R., Malkin D., et al. Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 2008, 26:1818-1830.
8. Kato T, Sawada H, Maruyama J, et al. Chronic hypoxia increases bone marrow-derived endothelial cells of non-hematopoietic stem cell origin, as well as macrophages of hematopoietic stem cell origin, in pulmonary vascular lesions in mice: differential roles of bone marrow-derived hematopoietic and non-hematopoietic stem cells in pulmonary hypertension. Circulation 2008;118(Suppl.):755 [abstract 2624].
9. Miyashita H., Higa K., Kato N., et al. Hypoxia enhances the expansion of human limbal epithelial progenitor cells in vitro. Invest Opth Visual Sci 2007, 48:3586-3593.
10. Danet G.H., Pan Y., Luongo J.L., et al. Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest 2003, 112:126-135.
11. Bishopric N.H., Discher D.J., Kaiser S., et al. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. JCI 1999, 104:239-252.
12. Schmaltz C., Hardenbergh P.H., Wells A., Fisher D.E. Regulation of proliferation-survival during tumor cell hypoxia. Mol Cell Biol 1998, 18:2845-2854.
13. Tannock I.F., Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989, 49:4373-4384.
14. + antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin - one single nature. Biochim Biophys Acta 2005, 1756:1-24.
15. Lagadic-Gossmann D., Hue L., Lecureur V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ 2004, 11:953-961.
16. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J 2000, 14:2185-2197.
17. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Medicine 1997, 3:177-182.
18. Chiche J., Ile K., Laferriere J., et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009, 69:358-368.
19. Hoogsteen I.J., Marres H.A.M., Wijffels K.I.E.M., et al. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin Cancer Res 2005, 11:97-106.
20. Unpublished study, manuscript submitted.
21. Perona R., Serrano R. Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pump. Nature 1988, 334:438-440.
22. Sonveaux P, Vegran F, Schroeder T, et al. Targeting lactate-fueled respiration selectively kills hypoxic cells in mice. JCI 2008;118:3930-42. doi:10.1172/jJCI36843. doi:10.1172/jJCI36843.
23. Galluzzi L., Maiuri M.C., Vitale I., et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007, 14:1237-1266.
24. Izumi H., Torigoe T., Ishiguchi H., et al. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev 2003, 29:541-549.
25. Galluzzo M., Pennacchietti S., Rosano S., et al. Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis. JCI 2009, 119:865-875.
26. Giaccia A., Siim B.G., Johnson R.S. HIF-1 as a target for drug development. Nat Rev Drug Dis 2003, 2:1-9.
27. Tan C., de Noronha R.G., Roecker A.J., et al. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res 2005, 65:605-612.
28. Kong D., Park E.J., Stephen A.G., et al. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA binding activity. Cancer Res 2005, 65:9047-9055.
29. Bennewith K.L., Raleigh J.A., Durand R.E. Orally administered pimonidazole to lab el hypoxic tumor cells. Cancer Res 2002, 62:6827-6830.